NCT03378960View on ClinicalTrials.gov

Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 23, 2015

Study Completion Date

February 29, 2016

Conditions
Bariatric Surgery Candidate
Interventions
DRUG

Omeprazole 20mg

Trial Locations (1)

28040

Fundacion para Investigación Biomedica Hospital Clinico San Carlos, Madrid

All Listed Sponsors
collaborator

Fundación Mutua Madrileña

OTHER

lead

Emilio Vargas Castrillón

OTHER

NCT03378960 - Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity | Biotech Hunter | Biotech Hunter